Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-03
2006-10-03
Hui, San-Ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07115604
ABSTRACT:
Levosimendan, or (−)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile, which has been previously suggested for the treatment of congestive heart failure, is useful in the treatment of erectile dysfunction.
REFERENCES:
patent: 5565466 (1996-10-01), Gioco et al.
patent: 5569657 (1996-10-01), Nore et al.
patent: 43 38 948 (1995-05-01), None
patent: 0 565 546 (1993-10-01), None
patent: WO 91/16052 (1991-10-01), None
patent: WO 92/12135 (1992-07-01), None
patent: WO 93/21921 (1993-11-01), None
patent: WO 98/01111 (1998-01-01), None
patent: WO 99/32081 (1999-01-01), None
patent: WO 99/21558 (1999-05-01), None
patent: WO 99/66912 (1999-12-01), None
Gomaa et al., BMJ 1996; 312: 1512-1515.
Stig Sundberg, Ph.D. et al., “Hemodynamic and Neurohumoral Effects of Levosimendan, a New Calcium Sensitizer, at Rest and During Exercise in Healthy Men”, The American Journal of Cardiology, vol. 75, pp. 1061-1066, May 15, 1995.
J. Lilleberg et al., “Dose-Range Study of a New Calcium Sensitizer, Levosimendan, in Patients with Left Ventricular Dysfunction”, Journal of Cardiovascular Pharmacology, 26 (Suppl. 1):S63-S69, 1995.
Esa-Pekka Sandell et al., “Pharmacokinetics of Levosimendan in Healthy Volunteers and Patients with Congestive Heart Failure”, Journal of Cardiovascular Pharmacology, 26 (Suppl. 1):S57-S62, 1995.
J. Lilleberg et al., “Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting”, European Heart Journal (1998) 19, 660-668.
J.H. Naude et al., “Topical treatment of erectile dysfunction did not show results,” BMJ, vol. 316, p. 1318 (1998).
Lue, “Erectile Dysfunction,” The New Englsnd Journal of Medicine, vol. 342, pp. 1802-1813 (2000).
Lehtonen Lasse
Lilleberg Jyrki
Pentikäinen Pertti
Finnegan Henderson Farabow Garrett & Dunner LLP
Hui San-Ming
Lilleberg Jyrki
Orion Corporation
LandOfFree
Method for treating erectile dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating erectile dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating erectile dysfunction will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3712747